RSS-Feed abonnieren
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0041-1731400
A Novel Technique for the Treatment of a Case of Verneuil's Disease of Perineum and Axillary Regions
Funding This research received funding from Medispharm, the local agent and supplier of Genadyne's NPWT, Integra Dermal Regeneration template TM and MEDIHONEY Gel.A.K., H.A., G.R.A, A.N., G.B., E.A.F., G.R.N., H.B.M., H.A.K.M., S.I., and E.E.H. reports grants from Medispharm, during the conduct of the study.
![](https://www.thieme-connect.de/media/10.1055-s-00028781/202103/lookinside/thumbnails/10-1055-s-0041-1731400_210003-1.jpg)
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory disease involving apocrine glands of the skin. It carries out an important burden on the daily life of the patient. Unfortunately, it presents a major concern for medical care management in the absence of clear guidelines for proper medical and surgical treatment. Hence, we report a case of concomitant axillary and perianal HS. We opted for surgical management using a novel technique, which proved efficacy for a year of follow-up recurrence free.
Keywords
Verneuil - hidradenitis suppurativa - Etanercept - Integra - synthetic - case report - novel techniqueNote
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
Publikationsverlauf
Eingereicht: 09. Januar 2021
Angenommen: 12. April 2021
Artikel online veröffentlicht:
19. Juli 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A Comparison of International Management Guidelines for Hidradenitis Suppurativa. Dermatology 2019; 1-16
- 2 Sivanand A, Alhusayen R, Piguet V, Alavi A. “Hidradenitis suppurativa” is a historical term that does not reflect the current understanding of disease pathogenesis. J Cutan Med Surg 2020; 24 (06) 644-645
- 3 Duran C, Baumeister A. Recognition, diagnosis, and treatment of hidradenitis suppurativa. JAAPA 2019; 32 (10) 36-42
- 4 Rowland Payne PCME. Hidradenitis suppurativa treatment - medical or surgical?. J Eur Acad Dermatol Venereol 2019; 33 (06) 981-982
- 5 Gulliver W, Landells IDR, Morgan D, Pirzada S. Hidradenitis suppurativa: a novel model of care and an integrative strategy to adopt an orphan disease. J Cutan Med Surg 2018; 22 (01) 71-77
- 6 Melendez Gonzalez MDM, Sayed CJ. Surgery is an essential aspect of managing patients with hidradenitis suppurativa. J Am Acad Dermatol 2020; 83 (03) 979-980
- 7 Tchero H, Herlin C, Bekara F, Fluieraru S, Teot L. Hidradenitis suppurativa: a systematic review and meta-analysis of therapeutic interventions. Indian J Dermatol Venereol Leprol 2019; 85 (03) 248-257
- 8 Manfredini M, Garbarino F, Bigi L, Pellacani G, Magnoni C. Hidradenitis suppurativa: surgical and postsurgical management. Skin Appendage Disord 2020; 6 (04) 195-201